Fig. 1From: Kinetics of CD169, HLA-DR, and CD64 expression as predictive biomarkers of SARS-CoV2 outcomeExpression of monocyte CD169 in acutely SARS-CoV2-infected patients in the early phase of the disease and during the follow-up, according to the length of hospital stay. The overall trend to moCD169 downregulation in the long-term did not reach statistical significance, due to some patients with persistent positive swabs for SARS-CoV2Back to article page